Home
Conditions
Antibody-mediated Rejection

Clinical trial condition

Antibody-mediated Rejection

Explore clinical trials studying Antibody-mediated Rejection. Study availability and eligibility vary by location and protocol.

26 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Antibody-mediated Rejection trial results

Active, not recruiting

MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart Transplantation (LEONE-HT)

NCT05184426

Conditions: Antibody-mediated Rejection, Heart Transplant Rejection, Transplant Failure
Locations: Hospital Universitario Puerta de Hierro Majadahonda Majadahonda, Madrid, Spain

Hospital General Universitario Gregorio Marañon Madrid, Spain

Hospital Universitario 12 de Octubre Madrid, Spain

View Trial Details

Completed

VIRTUUS Children's Study

NCT03719339

Conditions: Acute Cellular Graft Rejection, Antibody-mediated Rejection, BK Virus (Nephropathy), +17 more
Locations: University of California-San Diego, Rady Children's Hospital La Jolla, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

University of California Los Angeles, California, United States

Stanford University Palo Alto, California, United States

View all 13 locations

View Trial Details

Completed

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

NCT03737136

Conditions: Antibody-mediated Rejection
Locations: SBMU Tehran, Iran

View Trial Details

Completed

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

NCT04541914

Conditions: ABO Blood Type Incompatible Kidney Transplantation, Antibody-mediated Rejection
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

NCT03380377

Conditions: Antibody-mediated Rejection, Kidney Transplant Rejection, Kidney Transplant; Complications, +3 more
Locations: Norko Ammerman Los Angeles, California, United States

View Trial Details

Completed

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

NCT04897438

Conditions: Antibody-mediated Rejection, Kidney Transplant Failure, Kidney Transplant Rejection
Locations: Charité-Universitätsmedizin Berlin, Germany

View Trial Details

Completed

Felzartamab in Late Antibody-Mediated Rejection

NCT05021484

Conditions: Antibody-mediated Rejection
Locations: Medical University of Vienna Vienna, Austria

Charité University Berlin, Germany

View Trial Details

Completed

Desensitization in Kidney Allograft Using Daratumumab

NCT04204980

Conditions: Allosensitization, Antibody-mediated Rejection, Kidney Transplant Rejection
Locations: Henri Mondor Créteil, France

View Trial Details

Completed

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

NCT04026087

Conditions: Antibody-mediated Rejection
Locations: CHU Lapeyronie Montpellier, Hérault, France

View Trial Details

Completed

Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

NCT03388008

Conditions: Antibody-mediated Rejection, Lung Transplant Rejection
Locations: Washington University School of Medicine St Louis, Missouri, United States

Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Antibody-mediated Rejection

Antibody-mediated Rejection trial results

Related conditions